These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7060323

  • 1. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.
    McAllister RG, Kirsten EB.
    Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323
    [Abstract] [Full Text] [Related]

  • 2. Systemic availability of oral verapamil and effect on PR interval in man.
    Johnston A, Burgess CD, Hamer J.
    Br J Clin Pharmacol; 1981 Sep; 12(3):397-400. PubMed ID: 7295469
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Verapamil disposition kinetics in chronic atrial fibrillation.
    Kates RE, Keefe DL, Schwartz J, Harapat S, Kirsten EB, Harrison DC.
    Clin Pharmacol Ther; 1981 Jul; 30(1):44-51. PubMed ID: 7237897
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Verapamil kinetics in normal subjects and patients with coronary artery spasm.
    Freedman SB, Richmond DR, Ashley JJ, Kelly DT.
    Clin Pharmacol Ther; 1981 Nov; 30(5):644-52. PubMed ID: 7297023
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prolongation of verapamil elimination kinetics during chronic oral administration.
    Schwartz JB, Keefe DL, Kirsten E, Kates RE, Harrison DC.
    Am Heart J; 1982 Aug; 104(2 Pt 1):198-203. PubMed ID: 7102502
    [Abstract] [Full Text] [Related]

  • 11. Near-total reduction in verapamil bioavailability by rifampin. Electrocardiographic correlates.
    Barbarash RA, Bauman JL, Fischer JH, Kondos GT, Batenhorst RL.
    Chest; 1988 Nov; 94(5):954-9. PubMed ID: 3180898
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of verapamil in patients with renal failure.
    Mooy J, Schols M, v Baak M, v Hooff M, Muytjens A, Rahn KH.
    Eur J Clin Pharmacol; 1985 Nov; 28(4):405-10. PubMed ID: 4029246
    [Abstract] [Full Text] [Related]

  • 15. Lack of interaction between verapamil and cimetidine.
    Abernethy DR, Schwartz JB, Todd EL.
    Clin Pharmacol Ther; 1985 Sep; 38(3):342-9. PubMed ID: 4028631
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prediction of steady-state verapamil plasma concentrations in children and adults.
    Wagner JG, Rocchini AP, Vasiliades J.
    Clin Pharmacol Ther; 1982 Aug; 32(2):172-81. PubMed ID: 7094504
    [Abstract] [Full Text] [Related]

  • 18. The pharmacology of verapamil. III. Pharmacokinetics in normal subjects after intravenous drug administration.
    Dominic JA, Bourne DW, Tan TG, Kirsten EB, McAllister RG.
    J Cardiovasc Pharmacol; 1981 Aug; 3(1):25-38. PubMed ID: 6160352
    [Abstract] [Full Text] [Related]

  • 19. Clinical pharmacokinetics of verapamil in patients with atrial fibrillation.
    Anderson P, BondessoN U, Sylvén C.
    Eur J Clin Pharmacol; 1982 Aug; 23(1):49-57. PubMed ID: 7128672
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.
    Somogyi A, Albrecht M, Kliems G, Schäfer K, Eichelbaum M.
    Br J Clin Pharmacol; 1981 Jul; 12(1):51-60. PubMed ID: 7248141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.